Correlation Between NewAmsterdam Pharma and Zenith Capital
Can any of the company-specific risk be diversified away by investing in both NewAmsterdam Pharma and Zenith Capital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NewAmsterdam Pharma and Zenith Capital into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NewAmsterdam Pharma and Zenith Capital Corp, you can compare the effects of market volatilities on NewAmsterdam Pharma and Zenith Capital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NewAmsterdam Pharma with a short position of Zenith Capital. Check out your portfolio center. Please also check ongoing floating volatility patterns of NewAmsterdam Pharma and Zenith Capital.
Diversification Opportunities for NewAmsterdam Pharma and Zenith Capital
0.07 | Correlation Coefficient |
Significant diversification
The 3 months correlation between NewAmsterdam and Zenith is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and Zenith Capital Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zenith Capital Corp and NewAmsterdam Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NewAmsterdam Pharma are associated (or correlated) with Zenith Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zenith Capital Corp has no effect on the direction of NewAmsterdam Pharma i.e., NewAmsterdam Pharma and Zenith Capital go up and down completely randomly.
Pair Corralation between NewAmsterdam Pharma and Zenith Capital
Assuming the 90 days horizon NewAmsterdam Pharma is expected to generate 50.29 times less return on investment than Zenith Capital. But when comparing it to its historical volatility, NewAmsterdam Pharma is 18.19 times less risky than Zenith Capital. It trades about 0.07 of its potential returns per unit of risk. Zenith Capital Corp is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest 8.00 in Zenith Capital Corp on September 1, 2024 and sell it today you would earn a total of 3.00 from holding Zenith Capital Corp or generate 37.5% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 95.45% |
| Values | Daily Returns |
NewAmsterdam Pharma vs. Zenith Capital Corp
Performance |
| Timeline |
| NewAmsterdam Pharma |
| Zenith Capital Corp |
NewAmsterdam Pharma and Zenith Capital Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NewAmsterdam Pharma and Zenith Capital
The main advantage of trading using opposite NewAmsterdam Pharma and Zenith Capital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NewAmsterdam Pharma position performs unexpectedly, Zenith Capital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zenith Capital will offset losses from the drop in Zenith Capital's long position.| NewAmsterdam Pharma vs. NewAmsterdam Pharma | NewAmsterdam Pharma vs. Scilex Holding | NewAmsterdam Pharma vs. OmniAb Inc |
| Zenith Capital vs. Rigel Pharmaceuticals | Zenith Capital vs. Geron | Zenith Capital vs. Verastem | Zenith Capital vs. Immutep Ltd ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |